DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/z8gzhq/european_uterine) has announced the addition of the "European Uterine Fibroid Embolization Device Market" report to their offering.
During this procedure, a small incision is made in the groin, and a small catheter is inserted into the nearby artery. X-ray imaging is used for guiding the catheter through the artery into the uterus. A mixture of minuscule plastic particles and X-ray dye is then injected into the artery, flowing and accumulating in the fibroids and blocking the blood supply. The flow of particles is carefully monitored with the X-ray equipment by watching the flow of dye. This procedure can take anywhere from 40 minutes to three hours to complete. The fibroids shrink and disappear over a period of several months. UFE is a much less invasive way to treat fibroids than a hysterectomy, has a much shorter recovery time and leaves almost no scarring.
This report analyzes and evaluates the current state of the market, including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our ground up approach, which includes primary and secondary research methods.
Scope of Report:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment
- Trend Analysis by Segment
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback & Market Monitoring
For more information visit http://www.researchandmarkets.com/research/z8gzhq/european_uterine.